HKSE - Delayed Quote HKD

JD Health International Inc. (6618.HK)

Compare
28.600 -0.300 (-1.04%)
At close: 4:08 PM GMT+8
Loading Chart for 6618.HK
DELL
  • Previous Close 28.900
  • Open 28.900
  • Bid 28.700 x --
  • Ask 28.650 x --
  • Day's Range 28.450 - 29.100
  • 52 Week Range 19.480 - 40.850
  • Volume 7,986,624
  • Avg. Volume 13,422,442
  • Market Cap (intraday) 91.247B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) 31.78
  • EPS (TTM) 0.900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 31.86

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

ir.jdhealth.com

3,177

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6618.HK

View More

Performance Overview: 6618.HK

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

6618.HK
26.85%
HANG SENG INDEX
14.98%

1-Year Return

6618.HK
28.32%
HANG SENG INDEX
10.25%

3-Year Return

6618.HK
61.79%
HANG SENG INDEX
21.75%

5-Year Return

6618.HK
69.74%
HANG SENG INDEX
25.48%

Compare To: 6618.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6618.HK

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    92.20B

  • Enterprise Value

    40.92B

  • Trailing P/E

    31.99

  • Forward P/E

    22.73

  • PEG Ratio (5yr expected)

    0.96

  • Price/Sales (ttm)

    1.55

  • Price/Book (mrq)

    1.64

  • Enterprise Value/Revenue

    0.70

  • Enterprise Value/EBITDA

    11.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.78%

  • Return on Assets (ttm)

    0.77%

  • Return on Equity (ttm)

    5.19%

  • Revenue (ttm)

    54.76B

  • Net Income Avi to Common (ttm)

    2.62B

  • Diluted EPS (ttm)

    0.900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.92B

  • Total Debt/Equity (mrq)

    0.42%

  • Levered Free Cash Flow (ttm)

    3.92B

Research Analysis: 6618.HK

View More

Company Insights: 6618.HK

Research Reports: 6618.HK

View More

People Also Watch